HDAC inhibitors overcome first hurdle

MeSH terms

• Clinical Trials as Topic / trends
• Drug Approval*
• Heart Diseases / chemically induced*
• Histone Deacetylase Inhibitors*
• Humans
• Hydroxamic Acids / adverse effects*
• Hydroxamic Acids / therapeutic use*
• Neoplasms / drug therapy*
• Risk Assessment
• United States
• United States Food and Drug Administration*
• Vorinostat